Viral MicroRNAs Identified in Human Dental Pulp by Zhong, Sheng et al.
Viral microRNAs Identified in Human Dental Pulp
Sheng Zhong, DDS, MS1,2,#, Afsar Naqvi, PhD3,#, Eric Bair, PhD2, Salvador Nares, PhD, 
DDS3, and Asma Khan, BDS, PhD2
1Endodontic Associates, MN
2Department of Endodontics, University of North Carolina, Chapel Hill, NC
3Department of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL
Abstract
Introduction—MicroRNAs (miRs) are a family of non-coding RNAs that regulate gene 
expression. They are ubiquitous among multicellular eukaryotes and are also encoded by some 
viruses. Upon infection, viral miRs (vmiRs) can potentially target gene expression in the host and 
alter the immune response. While prior studies have reported viral infections in human pulps, the 
role of vmiRs in pulpal disease is yet to be explored. The purpose of this study was to examine the 
expression of vmiRs in normal and diseased pulps and to identify potential target genes.
Methods—Total RNA was extracted and quantified from normal and inflamed human pulps 
(N=28). Expression profiles of vmiRs were then interrogated using miRNA Microarrays (V3) and 
the miRNA Complete Labeling and Hyb Kit (Agilent Technologies, Santa Clara, CA). To identify 
vmiRs that were differentially expressed, we applied a permutation test.
Results—Of the 12 vmiRs detected in the pulp, 4 vmiRs (including those from herpes virus and 
human cytomegalovirus) were differentially expressed in inflamed pulps as compared to normal 
pulps (p<.05). Using bioinformatics we identified potential target genes for the differentially 
expressed vmiRs. They included key mediators involved in the detection of microbial ligands, 
chemotaxis, proteolysis, cytokines and signal transduction molecules.
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Conclusions—This data suggests that miRs may play a role in interspecies regulation of pulpal 
health and disease. Further research is needed to elucidate the mechanisms by which vmiRs can 
potentially modulate the host response in pulpal disease.
Introduction
MicroRNAs (miRs) are 21-24 nucleotides (nt) long, single stranded, non-coding RNAs. By 
fine-tuning the transcriptome, they regulate most fundamental biological processes including 
cell differentiation, signaling, cell death and pathogen response (1,2). miRs are transcribed 
as long precursor transcripts called primary-miRs (pri-miRs) by RNA polymerase II. The 
localized stem-loop structure on pri-miR is recognized by Drosha to release ~60-80 nt pre-
miR in the nucleus. These imperfectly paired stem-loops are exported to the cytoplasm and 
are processed by Dicer to enzymatically generate miR duplexes. Of the two strands, the 
mature miR strand is finally loaded onto RNA-induced silencing complexes (mi-RISC) 
while the passenger (star) strand is generally degraded. The mature miR guides the protein 
machinery to regulate mRNAs and eventually affects translation.
Recent studies show that viruses, especially those with DNA genome, encode miRs in order 
to regulate their life cycle inside the host (3-5). The viral transcripts generated in the nucleus 
are recognized by the host proteins and processed in a way similar to the canonical miR 
pathway. Viral pri-miRs are primarily transcribed by polymerase II; however, it has been 
shown that polymerase III generates tRNA-like miR precursors in murine gamma 
herpesvirus type 68 (6). Following the discovery of vmiRs in Epstein-Barr virus (EBV), 
several herpesvirus families were later found to encode miRs. To date, more than 250 
different miRs of viral origin have been identified and the list continues to expand (7).
Herpesviruses are large, double-stranded DNA viruses that infect a range of invertebrate and 
vertebrate animals. There are 8 types that infect humans: herpes simplex viruses 1 and 2 
(HSV 1 and 2), varicella-zoster virus, EBV, human cytomegalovirus (HCMV), human 
herpesvirus 6, human herpesvirus 7, and Kaposi's sarcoma-associated herpesvirus (KSHV). 
The genomic locations of alpha (e.g. HSV 1 and 2) and gamma (e.g. EBV, KSHV) 
herpesviruses miRs are clustered generally in the vicinity of latency associated regions, 
however, beta herpesvirus (e.g. HCMV) are scattered throughout the viral genome. The 
expression profiles of vmiRs are restricted to specific stages of the virus life cycle. For 
instance, most of the miRs in KSHV and EBV are expressed during latency while HSV-1 
miR-H1 and few HCMV miRs are expressed during the productive stages of the infection.
VmiRs may regulate both viral and/or host transcripts. Several vmiRs target viral genes to 
which they are antisense, e.g., EBV miR-BART2 targeting BALF5 gene while, others 
control transcripts emanating from other genomic locations, e.g., HSV-1 miR-H6 targeting 
ICP4 (3,8). Target identification reveals that several vmiRs regulate the same target, a 
feature commonly observed in mammalian system. For instance, HSV-1 miR-H3 and miR-
H4 regulate the level of pathogenesis factor ICP34.5 while EBV latent membrane protein 1 
(LMP1) is controlled by three different vmiRs (3).
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Modulation of host genes is another function of viral miRs. Given the capacity to regulate 
hundreds of probable host transcripts, vmiRs have the potential to significantly influence the 
host transcriptome. Global transcriptome profiling has revealed the set of host genes under 
direct influence of vmiRs. Unlike metazoan miRs, vmiRs exhibit limited sequence 
conservation even in closely related families indicating their functional divergence (9). 
Furthermore, emerging evidence shows that KSHV miRs exert a protective function by 
targeting IKBA and NF-κB pathways and thus rescuing cell cycle progression and inhibiting 
apoptosis. Intricate interactions of KSHV miRs with other viral oncogenes are likely to 
maintain or break the fine balance between uncontrolled cell growth and cell homeostasis, 
and are therefore, essential for KSHV-induced cellular transformation (10).
The oral cavity is an ecological niche of diverse microbial species. Several bacterial and 
viral species are known to coexist in the same oral environment. Both gram positive and 
gram negative bacteria are known as causal agents for various oral diseases. Herpesviruses 
are the predominantly detected family of viruses in such infections. Under “healthy” 
conditions, this indigenous microflora remains benign and assists the host by maintaining 
basal host immunity, thereby establishing symbiotic association. Influenced by various 
external and internal factors, however, this equilibrium may be disturbed leading to 
modulated immune responses (11).
Although viruses have been found in diseased pulps and periapical tissues, a causal 
relationship between viral infection and endodontic disease is yet to be established. Ferriera 
et al. reported that 48% of apical abscesses samples had KSHV infections, whereas Chen et 
al. detected HCMV in 29% of the patients with similar disease (12,13). A more recent study 
suggested that B cells and plasma cells in inflamed granulomas are a major source of EBV 
infection, and that EBV could play a pivotal role in controlling immune cell responses in 
periapical granulomas (11). The prevalence of herpesviruses varies across different reports, 
nonetheless, it is recognized that they may act as opportunistic infections. The presence of 
herpesviruses in HIV-infected patients further supports the notion that these pathogens are 
activated when the hosts’ immunity is compromised (14).
Although the role of these viruses in augmenting the disease has been proposed, there is 
little information on how they contribute towards pathogenesis. It is likely that one 
mechanism by which they augment pulpal and periapical disease is by reshaping the host 
immune response via vmiRs. To explore this, we first compared the viral encoded miR 
profiles in healthy and diseased human pulps. We then used in silico target prediction of the 
differentially expressed vmiRs to identify the potential host target genes that are vital in 
defense against pathogens.
Materials and Methods
Study participants and sample collection
This study was approved by the Institutional Review Board, at the University of North 
Carolina at Chapel Hill and conforms to the STROBE guidelines for reporting observational 
studies (http://www.strobe-statement.org). Written informed consent was obtained from 28 
participants who were recruited from the School of Dentistry, University of North Carolina 
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at Chapel Hill. The inclusion criteria were ≥12 years old and American Association of 
Anesthesiologists status I or II. Patients who had a compromised immune system or those 
who were taking medications known to influence the immune response were excluded from 
the study. Participants were enrolled into two groups based on the pulpal status of the teeth 
being treated. Normal pulps were extirpated from healthy third molars or teeth extracted for 
orthodontic purpose. These did not include teeth with carious lesions or deep (≥5mm) 
probing defects. Diseased pulps were extirpated from carious teeth diagnosed with 
irreversible pulpitis defined with either carious pulpal exposures or the presence of 
spontaneous pain and an exaggerated and lingering response to cold (1,1,1,2-
tetrafluoroethane) (15).
After obtaining informed consent, local anesthesia was administered. For teeth diagnosed 
with normal pulps, the teeth were extracted and the root canal system immediately accessed. 
The pulp was then extirpated using a sterilized barbed broach or Hedstrom hand file. For 
teeth diagnosed with diseased pulps, rubber dam isolation was obtained and the tooth and 
rubber dam were disinfected with 0.2% chlorhexidine gluconate. The carious tooth structure 
was removed and then the root canal system was accessed. Pulp tissue was collected using a 
sterilized barbed broach or Hedstrom hand file. Pulp tissue was gently separated from the 
instrument and placed in a sterile eppendorf tube with 0.5ml RNAsafer Stabilizer Reagent 
(VWR, Bridgeport, NJ). All samples were stored at −80° C until processing.
RNA isolation and miRNA microarray
Samples were thawed on ice and centrifuged at 4°C for 2 minutes at 12,000 rpm to remove 
the stabilizer reagent. Total RNA was extracted using the miRNeasy Mini kit (Qiagen, 
Valencia, CA) according to manufacturer's instructions. The RNA was quantitated using the 
NanoDrop (Thermo Scientific, Wilmington, DE) and RNA integrity assessed using the 2100 
Bioanalyzer (Agilent, Foster City, CA). The miRNA expression profiles of normal and 
diseased pulps were interrogated using Human miRNA Microarrays (V3) and the miRNA 
Complete Labeling and Hyb Kit (both from Agilent Technologies, Santa Clara, CA). The 
microarrays consist of glass slides containing 8 identical 15K oligonucleotide microarrays 
incorporating probes for 866 human and 89 human viral miRNAs represented from the 
Sanger miRBase 12.0. The procedure was performed as described previously (16). Briefly, 
300 ng of total RNA samples were dephosphorylated, denatured by dimethyl sulfoxide, and 
then immediately transferred to ice-water bath for ligation. The samples were incubated with 
T4 RNA ligase at 16°C in a circulating water bath for 2 hours. Labeled miRNAs were 
desalted through Micro Bio-spin 6 columns (Bio-Rad, Hercules, CA) for purification. 
Samples were hybridized at 55° C for 20 hours at 20 rpm in a rotating hybridization oven. 
The microarray slides were then washed using fresh wash buffer. Finally, the slides were 
scanned using the Agilent Microarray Scanner and the Agilent Feature Extraction Software 
version 10.5.1.1 (Agilent, Foster City, CA).
Statistical analysis
For microarray data analysis, any expression value that was lower than the reported error for 
that particular gene (which includes negative expression values) was set to be equal to the 
estimated error rate. Quantile normalization was applied to the expression data. To identify 
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genes that were differentially expressed in each group, we applied a permutation test to test 
the null hypothesis that the mean expression of each gene was the same in both groups. An 
exact hypothesis test was used since the sample size was small. We used the resulting p-
values to estimate the false discovery rate q-value when the differential expression of each 
miR is called “significant”. Since we performed multiple hypothesis tests, the usual p<0.05 
threshold for significance was too liberal for this analysis. However, using the Bonferroni-
adjusted significance threshold (p<0.05/335) would be too conservative and result in a less 
of power given our small sample size. Thus, for each p-value, we computed the q-value, 
which is defined to be the false discovery rate when all tests with a p-value less than or equal 
to the given p-value are called “significant”. This allows us to control type I error while 
avoiding the power loss that would result from using a Bonferroni correction.
Bioinformatics miRNA analysis and target selection
To identify the viral miRNA targets, we used viR-miR database (http://
alk.ibms.sinica.edu.tw). Viral miR sequences were entered into the search database and list 
of genes were procured as an output file. As an alternate, we also searched the 3′ UTR of 
some important genes employing the RNA hybrid algorithm that is used by viR-miR 
database.
Results
Twenty-eight patients were recruited into the study and from whom thirty teeth were used to 
collect dental pulps. The demographic data of the study subjects is summarized in Table 1. 
No difference was noted in gender distribution between the two groups although subjects 
from whom diseased pulps were collected were significantly older than those from whom 
normal pulps were collected (p<0.001). The latter group consisted primarily of younger 
individuals undergoing tooth extraction for orthodontic reasons or for removal of 3rd molars. 
None of the teeth in the normal pulp group were extracted due to carious or periodontal 
pathology. In the diseased group 12 teeth had carious pulpal exposure with no recent history 
of spontaneous pain or thermal sensitivity while the remaining 6 teeth had a carious lesion 
and were associated with spontaneous pain and/or lingering response to cold.
In our study, we identified four viral miRNAs that were expressed at higher level in diseased 
human dental pulp. HSV1-miR-H1, HCMV-miR-US4, HCMV-miR-UL70-3p, and KSHV-
miR-K12-3 were increased 3.84, 4.64, 5.36 and 3.81 folds respectively (p <0.05). We also 
detected HSV-miR-H6 and KSHV-miR-K12-10b that were expressed at higher level in 
diseased dental pulp; however, their levels were not statistically significant. We have also 
listed a few other viral miRNAs that were detected in our samples but did not show 
statistically significant changes.
To identify potential targets for the vmiRs differentially expressed in diseased pulps, we 
used viR-miR database (http://alk.ibms.sinica.edu.tw). We also searched PUBMED and 
confirmed the role of these vmiRs in inflammation, immunity and angiogenesis. The target 
genes comprise key mediators involved in the detection of microbial ligands (toll-like 
receptor 1{TLR1}), chemotaxis (Chemokine ligand 25), proteolysis (MMP24, matrix 
metalloprotease 24), pro-inflammatory and anti-inflammatory cytokines (IL8, IL-10) and 
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signal transduction molecules (Inducible T cell co-stimulator). The results of in silico studies 
are summarized in Table 3.
Discussion
Although the vast majority of our knowledge on pulpal disease is centered on bacterial 
infection, we are now increasingly aware of the potential role of viral infections or co-
infections in pulpal pathosis. The presence of viral infections in healthy and diseased pulps 
have been reported before (17,18,19). An observational study on viral infections in the pulp 
and periapical tissues reported the presence of HCMV in healthy and inflamed pulps (17). 
The same study found EBV in inflamed but not in normal pulps. Studies on HIV patients 
report detecting the virus in healthy pulp tissues as well as in pulp fibroblasts (17,18). A 
study on patients with chronic hepatitis C infections noted that the pulps had altered 
cellularity and vasculature. The tissue also contained increased mucosubstances and 
decreased fibronectin glycoprotein (20). A recent case report on the presence of Varicella 
Zoster virus in the root canal systems of teeth in a patient with trigeminal herpes zoster 
suggested an etiological role of the virus in pulpal and periapical disease (21).
The route by which viruses and their microRNA infect pulp cells is yet to be explored. As in 
bacterial infections, it may occur via a carious lesion. Another source may be from infected 
cells elsewhere in the body. Viruses secrete significant quantities of vmiRs into exosomes 
which merge and deliver their contents into recipient cells. In this manner vmiRs are 
disseminated to distant non-permissive cells including immune cells and modulate target cell 
functions. A third potential source for pulpal infection is via infected nerves as suggested in 
the recent case report on the presence of Varicella Zoster virus in the root canal systems 
(21).
To our knowledge, this is the first report on viral microRNA (vmiRs) in healthy and diseased 
pulps. By using microarray analysis, we were able to profile virus-derived miRs in both 
healthy and diseased human dental pulp. In our study, we detected twelve vmiRs with four 
of them significantly changed in diseased pulps. Prior studies show that vmiRs have the 
capacity to regulate hundreds of probable host transcripts and in this way can alter the hosts 
immune response (22, 23, 24).
Herpesvirus miRs were the predominantly identified group of vmiRs in our study. Herpes 
simplex viruses 1 and 2 (HSV-1 and -2) are members of the alpha subfamily and are 
important human pathogens, widely known as the causative agents of cold sores and genital 
herpes respectively. The initial herpesvirus infection is followed by a latent phase in host 
cells, which ensures the survival of the viral genome throughout the lifetime of infected 
individuals. Typically, the primary site of infection is mucosal epithelium, where the virus 
enters cells and starts its productive cycle. The productive cycle entails a cascade of gene 
expression, viral DNA replication, and assembly and egress of infectious virus. In the host, 
virus can enter sensory neurons that innervate the site of primary infection and establish 
lifelong latent infection in which no infectious virus is detected, but from which virus can 
reactivate and cause recurrent disease. Study by Cui et al experimentally detected HSV1-
miR-H1 that was expressed during productive infection from HSV1-infected Vero cells (25). 
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In our study, HSV1-miR-H1 was expressed at an induced level (3.84 fold higher) in diseased 
human dental pulp indicating either increased viral replication in the infected cells or 
accumulation of latently infected cells.
Interestingly, we also detected some vmiRs in control tissues from healthy subjects, albeit at 
low levels. However, it is not very surprising considering that human herpes virus persists as 
latent lifelong subclinical infection and that several viral miRs are either expressed 
exclusively or at higher levels during latency which is the predominant phase of viral life 
cycle. Indeed, in our study we identified several EBV BART miRs that are derived from 
latency associated BART transcript. Moreover, vmiRs, similar to host miRNAs, can target 
exosomes which are nanovesicles (~40-100 nm) secreted by various cells. These 
extracellular vesicles, through endocytic pathway, can merge and deliver their contents 
including proteins, mRNA and miRNAs into recipient cells (26, 27). Upon endocytosis, the 
exosomes release their contents to recipient cells that can modulate their functions or 
responses. Recent studies have demonstrated vmiRs in the exosomes of EBV and KSHV 
infected cells (27, 28). As mentioned before, viruses can secrete significant quantities of 
vmiRs into exosomes to be disseminated across distant non-permissive cells including 
immune cells. Evidently, several reports demonstrate that vmiRs specifically downregulate 
genes of innate as well as adaptive immunity. For instance, KSHV-miRK10 directly target 
TNF-like weak inducer of apoptosis receptor (TWEAKR) leading to reduced expression of 
IL-8 and monocyte chemoattractant protein 1 (MCP1) (29). EBV, HCMV and KSHV 
encoded miRs can target the stress induced immune ligand MHC class I polypeptide-related 
sequence B (MICB) to escape recognition by natural killer cells (30). Similarly, in Primary 
Effusion Lymphoma patients, exosomes carrying KSHV vmiRs promote endothelial cell 
migration and thus augment angiogenesis (28).
Epstein–Barr virus (EBV) infects more than 90 % of the population and establishes lifelong 
persistence in the host despite immune responses (31). Innate and adaptive immunities, 
therefore, need to cope with primary and secondary encounters with EBV, in addition to its 
latency and reactivation. In a minority of infected individuals, EBV is strongly linked to a 
remarkable variety of nonmalignant and malignant tumors in humans (32). This successful 
lifelong persistence and, in particular, its ability to establish latency despite specific immune 
responses show that EBV has developed powerful strategies and mechanisms to exploit, 
evade, abolish, or downsize effective immune responses to ensure its own survival. EBV 
encodes at least 40 miRs that map to two regions of the viral genome. The BHRF1 miRs are 
located immediately upstream and downstream of the BHRF1 open reading frame, while the 
BART miRs lie within the intronic regions of the BARTs. Our study detected six different 
BART miRNAs viz., BART-10, -12, -14, -16, -19-3p and -3*. Among these, BART-12, -13 
and -19-3p showed higher expression levels. Compared to healthy control only BART-19-3p 
were downregulated, albeit not significant. Remaining BART miRs showed similar 
expression profiles in healthy and diseased pulp. Therefore, the potential clinical 
implications of the detected EBV BART miRNAs in pulpitis is highly remote.
Human cytomegalovirus belongs to the beta subfamily of herpesviridae and is a highly 
prevalent human pathogen, usually acquired at an early age. Following primary infection, 
the virus also establishes life-long latent infection with episodes of reactivation. Unlike most 
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of the herpesviridae, the miRs of HCMV are scattered along both strands of its genome, and 
are expressed through productive infection (33). We detected increased expression of miR-
US4 and miR-UL70 in inflamed pulps indicating a role of these vmiRs in immunity. 
Consistent with this, Kim et al., demonstrated the suppression of MHC class I antigen 
presentation by miR-US4 through targeting of antigen peptide generating enzyme 
endoplasmic reticulum aminopeptidase 1 (ERAP1) (34).
KSHV-miR-K12-3 is expressed during latent infection and is detected in the exosomes of 
infected human brain microvascular endothelial cells. As with other herpes virus encoded 
vmiRs, KSHV-miR-K12-3 regulates both viral and cellular genes. KSHV-miR-K12-3 
modulates the expression of replication and transcription activator (RTA) gene which is 
crucial for viral replication during lytic phase. This is achieved by repressing expression of 
Nuclear factor I/B (NFIB), an activator of RTA. Viral dissemination is promoted by KSHV-
miR-K12-3 through downregulation of C/EBPβ (CCAAT/enhancer-binding protein β), a 
transcriptional repressor of IL-6 and IL-10 that promote growth of KSHV-infected cells (35). 
KSHV-miR-K12-3 directly represses caspase 3 expression thereby preventing apoptosis of 
infected cells (36). Another important gene targeted by miR_K12-3-3p is thrombospondin 1 
(THBS1) which functions as an anti-angiogenic, anti-proliferative protein (37). THBS1 also 
induce immune response by recruiting monocytes and facilitate T cell migration (38, 39). In 
macrophages and dendritic cells, ectopic expression of KSHV-miR-K12-3 exhibit impaired 
phagocytosis and pro-inflammatory cytokines secretion upon challenge with heat-killed 
gram negative bacteria (Naqvi et al., Unpublished results). Together, these findings suggest 
diverse functional role of KSHV-miR-K12-3 in regulating viral life cycle, survival of 
infected cells and subversion of host immune responses.
The discovery of viral miRs has generated considerable attention into their functional 
relevance in processes such as cell death, viral proliferation, and oncogenesis. Could the 
vmiRs contribute to the endodontic disease pathogenesis? To address this question, we 
examined the miRNAs gene profile from both healthy and diseased human dental pulp. We 
found considerable vmiRs expressed in both groups and some of them are significantly 
changed in the diseased human dental pulp. Although the functions of these viral miRNAs 
are yet to be explored, our study provides potential direction for the future research.
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Table 1
Study participant demographics. Mann-Whitney U test was used to compare age and McNemar's Chi-square 
test was used to compare gender distribution between the two groups. Age is presented as mean ± standard 
deviation. Pain history is defined as patients’ report of spontaneous and/or thermally evoked pain in the past 14 
days.
Variables Normal pulp (n=12) Diseased pulp (n=18) p value
Mean Age (StdDev) 37 (14.42) 18 (3.00) <.0001
Gender
    Female 5 (42%) 10 (56%) 0.71
    Male 7 (48%) 8 (44%)
Pain History 0% 6 (30%)
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Table 2
vmiRs expressed in normal and diseased human dental pulp.
miRNA p value q value Healthy Diseased Fold change
ebv-miR-BART10 1.00 0.94 4.51 4.55 1.01
ebv-miR-BART12 0.88 0.94 37.50 42.21 1.13
ebv-miR-BART13 0.93 0.94 127.51 139.94 1.10
ebv-miR-BART16 1.00 0.94 18.31 18.14 0.99
ebv-miR-BART19-3p 0.17 0.42 104.01 59.41 0.57
ebv-miR-BART3* 0.95 0.94 8.02 8.48 1.06
hcmv-miR-UL70-3p 0.02 0.12 98.26 526.22 5.36
hcmv-miR-US4 0.01 0.05 19.67 91.24 4.64
hsv1-miR-H1 0.03 0.17 34.72 133.40 3.84
hsv1-miR-H6 0.24 0.53 12.93 26.57 2.05
kshv-miR-K12-10b 0.10 0.33 1.68 6.22 3.69
kshv-miR-K12-3 0.02 0.10 291.49 1110.32 3.81
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Table 3
Potential vmiR target genes were identified using viR-miR database http://alk.ibms.sinica.edu.tw
v-miRNA Target gene Abbrev Target Gene Gene Product Function GO term (accession, ontology)
hsv1 miR-H1 HOXC10 Homeobox C10 Plays a role in the 
morphogenesis in multi-
cellular organisms.
GO:0003677, Molecular Function
hsv1 miR-H1 MYD88 Myeloid differentiation 
primary response gene 88
Involved with immunity 
and inflammatory 
response
GO:0006954, Biological Process
hsv1-miR-H1-5p THBS1 Thrombospondin 1 Acts in immediate 
response to infection or 
injury causing local 
vasodilation, 
extravasation of plasma 
into intercellular spaces 
and production of white 
blood cells and 
macrophages
GO:0006954, Biological Process
hsv1-miR-H1-5p IL10 Interleukin 10 Pleiotropic effects in 
immunoregulation and 
inflammation, B-cell 
survival, proliferation, 
and antibody 
production, block 
nuclear factor kappa B 
activity
GO:0019969, Molecular Function
hsv1-miR-H1-5p IL8 Interleukin 8 Aids in chemotaxis in 
response to an external 
stimulus
GO:0006935, Biological Process
hsv1-miR-H1-5p ICOS Inducible T-Cell Co-Stimulator Plays an important role 
in cell-cell signaling, 
immune responses, and 
regulation of cell 
proliferation
GO:0052156, Biological Process
hsv1-miR-H1-5p FOS FBJ murine osteosarcoma viral 
oncogene homolog
Acts in regulation of 
transcription
GO:0006355, Biological Process
hsv1-miR-H1-5p CCR9 C-C chemokine receptor type 
9
Acts with receptor to act 
as a chemokine
GO:0031734, Biological Process
hsv1-miR-H1-5p CCR7 C-C chemokine receptor type 
7
Expressed to activate B 
and T lymphocytes, 
stimulate dendritic cell 
maturation, and thought 
to mediate EBV effects 
on B lymphocytes
GO:0031732, Molecular Function
hsv1-miR-H1-5p PLCB1 Phospholipase C, beta 1 Involved in the 
metabolism of lipids
GO:0006629, Biological Process
hcmv-miR-UL70-3p ADAM15 ADAM metallopeptidase 
domain 15
Involved in 
angiogenesis, negative 
regulation of cell-matrix 
adhesion, and negative 
regulation of cell growth
GO:0004896, Molecular Function
hcmv-miR-UL70-3p ATG4A Autophagy related 4A, 
cysteine peptidase
Involved with 
autophagy, transport of 
cells, and cell 
homeostasis and 
remodeling
GO:0006914, Biological Process
hcmv-miR-UL70-3p CCL25 Chemokine (C-C motif) ligand 
25
Involved with the 
immune response, cell 
chemotaxis and 
chemokine activity
GO:0006955, Biological Process
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v-miRNA Target gene Abbrev Target Gene Gene Product Function GO term (accession, ontology)
hcmv-miR-UL70-3p CCR9 Chemokine (C-C motif) 
receptor 9
Acts with receptor to act 
as a chemokine
GO:0031734, Biological Process
hcmv-miR-UL70-3p FOS FBJ murine osteosarcoma viral 
oncogene homolog
Implicated in regulation 
of transcription, 
differentiation, and 
transformation.
GO:0035556, Biological Process
hcmv-miR-UL70-3p GPR64 G protein-coupled receptor 64 Involved with cell 
surface receptor 
signaling and 
componentry with the 
cell membrane
GO:0007166, Biological Process
hcmv-miR-UL70-3p IL10 Interleukin 10 Pleiotropic effects in 
immunoregulation and 
inflammation, B-cell 
survival, proliferation, 
and antibody 
production, block 
nuclear factor kappa B 
activity
GO:0019969, Molecular Function
hcmv-miR-UL70-3p IL8 Interleukin 8 Involved in chemotaxis, 
neutrophil activation, 
and immune response
GO:0006955, Biological Process
hcmv-miR-UL70-3p IL1a Interleukin 1, alpha Involved in generation 
of fever in response to 
infection
GO:0001660, Biological Process
hcmv-miR-UL70-3p ICOS Inducible T cell co-stimulator Plays an important role 
in cell-cell signaling, 
immune responses, and 
regulation of cell 
proliferation
GO:0052156, Biological Process
hcmv-miR-UL70-3p ICAM1 Intercellular adhesion 
molecule 1
Plays a role in cell 
membrane componentry
GO:0016021, Cellular Component
hcmv-miR-UL70-3p IL6R Interleukin 6 receptor Acts as a cytokine 
receptor activator
GO:0006954, Biological Process
hcmv-miR-UL70-3p MMP24 Matrix metalloproteinase 24 Involved in cell-cell 
adhesion and cadherin 
adhesion
GO:0006355, Biological Process
hcmv-miR-UL70-3p PRKCA Protein kinase C, alpha Inloved in signal 
transduction pathways 
related to cell adhesion 
and transformation
GO:0001525, Biological Process
hcmv-miR-UL70-3p THBS1 Thrombospondin 1 Acts in immediate 
response to infection or 
injury causing local 
vasodilation, 
extravasation of plasma 
into intercellular spaces 
and production of white 
blood cells and 
macrophages
GO:0007155: Biological Process
kshv-miR-K12-3-5p ICAM1 Intercellular adhesion 
molecule 1
Plays a role in cell 
membrane componentry
GO:0016021, Cellular Component
kshv-miR-K12-3-5p ICOS Inducible T cell co-stimulator Plays an important role 
in cell-cell signaling, 
immune responses, and 
regulation of cell 
proliferation
GO:0052156, Biological Process
kshv-miR-K12-3-5p GPR64 G protein-coupled receptor 64 Acts as in cell surface 
signaling pathways and 
in membrane 
componentry
GO:0007166, Biological Process
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v-miRNA Target gene Abbrev Target Gene Gene Product Function GO term (accession, ontology)
kshv-miR-K12-3-5p FOS FBJ murine osteosarcoma viral 
oncogene homolog
Implicated in regulation 
of transcription, 
differentiation, and 
transformation.
GO:0006355, Biological Process
kshv-miR-K12-3-5p MRC1 Mannose receptor, C type 1 Involved in the 
recognition of 
carbohydrates 
importation in cell-cell 
recognition and 
neutralization of 
pathogens, and viral 
entry into the host cell
GO:0046718, Biological Process
kshv-miR-K12-3-5p PLCB2 Phospholipase C, beta 2 Involved in calcium ion 
binding and signal 
transduction
GO:0035556, Biological Process
kshv-miR-K12-3-5p PLCB4 Phospholipase C, beta 4 Involved in calcium ion 
binding and signal 
transduction
GO:0035556, Biological Process
kshv-miR-K12-3-5p TLR-1 Toll-like receptor 1 Associated with 
regulation of signaling 
pathways related to 
innate immunity, and 
initiate adaptive 
immunity
GO:0034130, Biological Process
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